Patrick F. Smith
ORCID:0000-0002-6003-0805
发表论文 410 篇 · 总被引 9639 次 · h-index 52
代表论文
- Timing of Antiviral Treatment Initiation is Critical to Reduce SARS‐CoV‐2 Viral Load (2020 · CPT Pharmacometrics & Systems Pharmacology · 被引 239)
- Model‐Informed Drug Development for Anti‐Infectives: State of the Art and Future (2021 · Clinical Pharmacology & Therapeutics · 被引 77)
- Pharmacokinetics and pharmacodynamics of inclisiran, a small interfering RNA therapy, in patients with hepatic impairment (2022 · Journal of clinical lipidology · 被引 72)
- Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168) (2021 · Clinical and Translational Science · 被引 53)
- Lumicitabine, an orally administered nucleoside analog, in infants hospitalized with respiratory syncytial virus (RSV) infection: Safety, efficacy, and pharmacokinetic results (2023 · PLoS ONE · 被引 32)
- Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19 (2020 · American Journal of Tropical Medicine and Hygiene · 被引 32)